Two cholesterol drugs, Zocor plus Zetia, increased the risk of death by 4% - Part 1
Hi, this is Larry Hobbs @ FatNews.com fatnews.com larryhobbs@fatnews.com A 4-year study found that the combination of two cholesterol-lowering drugs - Zocor (a statin) plus Zetia - did NOT reduce the total risk of death. In fact, the overall death rate was 4% higher in people given these drugs. This may have been due to random chance, but at the very least, it shows that that these drugs did absolutely no good whatsoever. But wait. There's more. People given these drugs had more cancer. People given these drugs had more congestive heart failure. People given these drugs had more strokes. People given these drugs had more violent or accidental deaths, which may have included suicides. People given these drugs had more deaths listed as "other" or "Could not be classifed". So the bottom line is These drugs did NOT reduce the risk of total risk of death but they DID increase the risk of cancer and death from other causes. I will post separate videos showing the increased risk of cancer and other problems associated with these drugs. How many doctors and patients would take these drugs if they were told the truth? That is, if they were told "These drugs will NOT reduce your risk of dying "But may increase your risk of cancer" " suicide" " violent or accidental death" " congestive heart failure and" " stroke." Furthermore, what if doctors and patients were also knew that These drugs have NEVER been shown to to benefit people over the age of 65 as noted in BusinessWeek, Jan 17 <b>...</b>
Lowering Bad Cholesterol Reduced Heart Problems in Kidney Patients ...
November 20 2010, 6:56 pm
http://prescriptions.blogs.nytimes.com/The Food and Drug Administration approved Zetia, which lowers LDL or “bad” cholesterol, in 2002 and Vytorin in 2004. Since then, these cholesterol drugs have been taken by millions of people and have had worldwide sales of $26.8 billion ...
Finally, A Win For Vytorin - Matthew Herper - The Medicine Show ...
November 20 2010, 6:56 pm
http://blogs.forbes.com/Vytorin combines Zocor, a generic that is the most prescribed cholesterol-lowering drug in America, with a newer medicine called Zetia that works differently from other cholesterol drugs. In 2008, an artery-imaging study failed to show ...
Anyone on the cholesterol drugs, Vytorin or Zetia - Meth Drug ...
November 20 2010, 6:56 pm
http://methdrugaddiction.com/Question by babyboomer: Anyone on the cholesterol drugs, Vytorin or Zetia? Front page news today -- Study finds the cholesterol-lowering drugs do not slow.
Finding Relief From High Cholesterol With Zetia
November 20 2010, 6:56 pm
http://lower-my-cholesterol.net/by Lorri37 Finding Relief From High Cholesterol With Zetia For millions of people, high cholesterol is a problem. Whether the cause is diet or.
Plavix questions and answers | Daily News Online
November 20 2010, 6:56 pm
http://e-blogzine.com/I have familial high cholesterol (genetic) and were Zetia (ezetimibe) for over a year now. I first tried taking a statin, but my body no good answer. I am a 20 year old very active individual hard – both physically and nutritionally ...
Zetia Does Not Reduce Heart Attack Risk
November 20 2010, 6:56 pm
http://lower-my-cholesterol.net/Recently, drug manufacturer Merck and chemical research company Schering-Plough announced a new medication to combat high cholesterol. Zetia, known chemically as Ezetimibe, is an anti-hyperlipidemic medication which is used to lower ...
Recent Study Questions Vytorin, Zeta Effectivenes to Lower ...
November 20 2010, 6:56 pm
http://saynotocholesterol.com/Lipitor, Zocor and other statin-type pharmaceuticals block cholesterol production in the liver, whereas Zetia blocks cholesterol absorption in the intestines. The difference between how the drugs reduce cholesterol has helped Zetia's ...
Merck Does The Right Thing - Robert Langreth - Treatments - Forbes
November 20 2010, 6:56 pm
http://blogs.forbes.com/Its Zetia cholesterol drug was brought to the market without performing the proper studies to show that it prevents heart attacks. Those studies are only now underway. But it's time to pause and commend Merck's current approach. ...
